SCHEMBL919517

SCHEMBL919517

CCOOC(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2762317 0.97
Acetonitrile SCHEMBL11673682 0.87 ALDH1A1 (0.34)
SCHEMBL4760584 0.82
Alcohol SCHEMBL3410011 0.78 ALDH1A1 (0.32)
SCHEMBL919515 0.78 ALDH1A1 (0.47)
SCHEMBL28439909 0.77
SCHEMBL3446870 0.77
Bicarbonate SCHEMBL10901198 0.76 ALDH1A1 (0.44)
SCHEMBL117701 0.75
SCHEMBL8747973 0.75 ALDH1A1 (0.45)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 101 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115340491-B Electrostatic-hydrogen bond chelating ionic liquid and preparation method and application thereof 井冈山大学 2023-08-01 CN disclosed
US-20230110065-A1 COMBINATION OF ANETHOLE TRITHIONE OR ITS DERIVATIVE, 4-OH-ANETHOLE TRITHIONE, WITH DOXYCYCLINE OR MINOCYCLINE FOR THE USE THEREOF IN THE TREATMENT OF PARKINSON'S DISEASE PETITJEAN OLIVIER (FR) 2023-04-13 US disclosed
US-11554106-B2 Prevention of the risks associated with drug-induced QT interval prolongation by using a specific inhibitor of the production of ROS of miochondrial origin CHILDS, MARC (FR) 2023-01-17 US disclosed
EP-4103175-A1 COMBINATION OF ANETHOLE TRITHIONE OR ITS DERIVATIVE, 4-OH-ANETHOLE TRITHIONE, WITH DOXYCYCLINE OR MINOCYCLINE FOR THE USE THEREOF IN THE TREATMENT OF PARKINSON'S DISEASE Petitjean, Olivier (FR) 2022-12-21 EP disclosed
CN-115340491-A Electrostatic-hydrogen bond chelating ionic liquid and preparation method and application thereof 井冈山大学 2022-11-15 CN disclosed
CN-115023420-A Pesticidally active fused bicyclic heteroaromatic compounds 先正达农作物保护股份公司 2022-09-06 CN disclosed
US-11400073-B2 Prevention and treatment of benign prostatic hyperplasia using a selective inhibitor of the production of reactive oxygen species of mitochondrial origin Petitjean, Olivier (FR) 2022-08-02 US disclosed
US-11333976-B2 Resin, photosensitive resin composition, electronic component and display device using the same TORAY INDUSTRIES, INC. (JP) 2022-05-17 US disclosed
US-20210289794-A1 COMPOSITIONS AND RELATED METHODS FOR AGRICULTURE FLAGSHIP PIONEERING INNOVATIONS V, INC. 2021-09-23 US disclosed
WO-2021160968-A1 COMBINATION OF ANETHOLE TRITHIONE OR ITS DERIVATIVE, 4-OH-ANETHOLE TRITHIONE, WITH DOXYCYCLINE OR MINOCYCLINE FOR THE USE THEREOF IN THE TREATMENT OF PARKINSON'S DISEASE PETITJEAN OLIVIER (FR) 2021-08-19 WO disclosed
US-4537714-A Process for the preparation of lower alkyl esters of N-L-α-aspartyl-L-phenylalanine and of new intermediates for their preparation EPROVA AG FORSCHUNGSINSTITUT (CH) 1985-08-27 US disclosed
EP-0099960-B1 PROCESS FOR THE PREPARATION OF LOWER ALKYL ESTERS OF N-L-ALPHA-ASPARTYL-L-PHENYL ALANINE, AND INTERMEDIATES FOR THEIR MANUFACTURE EPROVA AG Forschungsinstitut (CH) 1985-04-10 EP disclosed
EP-0042161-B1 K-41.C(2) ESTERS AND COMPOSITIONS CONTAINING THEM Shionogi &amp; Co., Ltd. (JP) 1984-05-09 EP disclosed
EP-0099960-A1 Process for the preparation of lower alkyl esters of N-L-alpha-aspartyl-L-phenyl alanine, and intermediates for their manufacture EPROVA AG Forschungsinstitut (CH) 1984-02-08 EP disclosed
US-4424212-A MITICIDES, ANTIPROTOZOA AGENTS, COCCIDIOSIS, POLYETHER ANTIBIOTICS SHIONOGI & CO., LTD. (JP) 1984-01-03 US disclosed
EP-0081971-A2 Novel cephalosporin compound and process for preparing the same Tanabe Seiyaku Co., Ltd. (JP) 1983-06-22 EP disclosed
US-4385176-A RING EXPANSION USING A LEWIS ACID FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1983-05-24 US disclosed
US-4308380-A 2-Lower alkyl-2 or 3-cephem-4-carboxylic acid derivatives FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1981-12-29 US disclosed
EP-0042161-A1 K-41.C(2) Esters and compositions containing them Shionogi &amp; Co., Ltd. (JP) 1981-12-23 EP disclosed
US-4113940-A ANTIMICROBIAL FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1978-09-12 US disclosed